New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 4, 2014
08:11 EDTCGIXCancer Genetics launches CALR mutation analysis test
Cancer Genetics has launched a genetic diagnostic test for detecting mutations in the calreticulin gene. This test helps physicians identify patients with certain types of myeloproliferative neoplasms, which are blood cancers that have the potential to evolve into acute leukemia. CGI is one of the first laboratories in the U.S. to offer this test under both CLIA and NY-State Approvals. Patients with the CALR mutation are understood to have more favorable disease outcomes as well as longer overall survival in comparison to patients who possess other biomarkers. Therefore, the results of the test could have implications in predicting a patient's outlook.
News For CGIX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 24, 2014
09:06 EDTCGIXCancer Genetics to host analyst day
Analyst Day to be held in Raleigh, North Carolina on September 25 at 10 am. Webcast Link
September 23, 2014
07:57 EDTCGIXCancer Genetics and Beth Israel Deaconess enter into collaboration
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use